M. Shiffman, B. Freilich, R. Vuppalanchi
Nov 14, 2018
Citations
4
Influential Citations
69
Citations
Quality indicators
Journal
Alimentary Pharmacology & Therapeutics
Abstract
Lipotoxicity leading to excessive caspase‐mediated apoptosis and inflammation is believed to drive liver damage in NAFLD. Emricasan is a pan‐caspase inhibitor that decreased serum ALT and apoptotic and inflammatory markers in subjects with chronic hepatitis.